The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis

The Efficacy of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis

<b>Background:</b> This study evaluated the efficacy and safety of pulmonary rehabilitation (PR) on functional performance, exercise-related oxygen saturation, and health-related quality of life among patients with idiopathic pulmonary fibrosis (IPF). <b>Methods:</b> A total...

Full description

Bibliographic Details
Main Authors:	Hee Eun Choi, Tae Hoon Kim, Ji Hoon Jang, Hang-Jea Jang, Jisook Yi, So Young Jung, Dae-Wook Kim, Jae Ha Lee
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Life
Subjects:	idiopathic pulmonary fibrosis pulmonary rehabilitation clinical efficacy functional performance exercise-related oxygen saturation health-related quality of life
Online Access:	https://www.mdpi.com/2075-1729/13/2/403

Similar Items

Idiopathic pulmonary fibrosis: current diagnosis and treatment
by: Alexandre Franco Amaral, et al.
Published: (2023-08-01)

Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study
by: Ho Young Lee, et al.
Published: (2023-10-01)

Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment
by: Yuji Iwanami, et al.
Published: (2022-09-01)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
by: Steven D. Nathan, et al.
Published: (2024-01-01)

Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01)

Idiopathic pulmonary fibrosis - a disorder of alveolar wound repair?
by: Swiss Medical Weekly
Published: (2003-07-01)

A qualitative exploration of people living with idiopathic pulmonary fibrosis experience of a virtual pulmonary rehabilitation programme
by: Orlagh O’Shea, et al.
Published: (2022-11-01)

Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
by: Roxana-Elena Cîrjaliu, et al.
Published: (2023-06-01)

Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
by: Ozalevli Sevgi, et al.
Published: (2010-02-01)

The Beneficial Impact of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Review of the Current Literature
by: Stefano Sanduzzi Zamparelli, et al.
Published: (2024-03-01)

Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Chance for a Multidisciplinary Treatment Approach
by: Seher Satar, et al.
Published: (2022-09-01)

The Role of Microbiome and Virome in Idiopathic Pulmonary Fibrosis
by: Paschalis Ntolios, et al.
Published: (2021-04-01)

Diagnostic Approaches for Idiopathic Pulmonary Fibrosis
by: Jae Ha Lee, et al.
Published: (2024-01-01)

Short-Term Effects of Comprehensive Pulmonary Rehabilitation and its Maintenance in Patients with Idiopathic Pulmonary Fibrosis: A Randomized Controlled Trial
by: Inga Jarosch, et al.
Published: (2020-05-01)

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
by: Dalia D. Hadi, et al.
Published: (2023-11-01)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
by: Spagnolo Paolo, et al.
Published: (2012-11-01)

Clinical course and management of idiopathic pulmonary fibrosis
by: Caitlin Quinn, et al.
Published: (2019-12-01)

Association between timing of intubation and mortality in patients with idiopathic pulmonary fibrosis
by: Eunhye Bae, et al.
Published: (2022-11-01)

Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
by: Aditi Chaudhary, et al.
Published: (2023-12-01)

Evaluation of repolarization dispersion in patients with idiopathic pulmonary fibrosis
by: Ferhat Eyyupkoca, et al.
Published: (2022-06-01)

Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis
by: Sheau-Ning Yang, et al.
Published: (2020-12-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
by: Maria S. Nashatyreva, et al.
Published: (2023-01-01)

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
by: Claudio Tirelli, et al.
Published: (2022-12-01)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
by: Filippo Patrucco, et al.
Published: (2023-03-01)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
by: Ioannis Tomos, et al.
Published: (2023-10-01)

IDIOPATHIC PULMONARY FIBROSIS. CORRECTION OF ERRORS
by: A. L. Yudin, et al.
Published: (2018-12-01)

Ambulatory oxygen therapy in lung transplantation candidates with idiopathic pulmonary fibrosis referred for pulmonary rehabilitation
by: Aline Paula Miozzo, et al.
Published: (2023-02-01)

The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
by: Saqib H. Baig, et al.
Published: (2024-01-01)

Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions
by: Anna Stainer, et al.
Published: (2021-06-01)

Pregnancy in a Patient with Idiopathic Pulmonary Fibrosis: A Case Report
by: Rebecca Horgan, et al.
Published: (2023-01-01)

The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis
by: Yahan Xu, et al.
Published: (2023-11-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
by: Paolo Cameli, et al.
Published: (2022-08-01)

Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
by: Yuko Ishida, et al.
Published: (2023-02-01)

Circular RNAs and their roles in idiopathic pulmonary fibrosis
by: Akshaya Surendran, et al.
Published: (2024-02-01)

Biomarkers of cellular senescence in idiopathic pulmonary fibrosis
by: Zaira Aversa, et al.
Published: (2023-04-01)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
by: Keisuke Anan, et al.
Published: (2022-10-01)

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
by: Sissel Kronborg-White, et al.
Published: (2021-11-01)

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio
by: S. N. Avdeev, et al.
Published: (2018-10-01)

Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment
by: Michelle B. Herberts, et al.
Published: (2023-08-01)

A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials
by: Xiaozheng Wu, et al.
Published: (2024-01-01)